Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification.

Clinical nuclear medicine - 1 Oct 2022

Kim Dongwoo, Chun Joong Hyun, Yi Ju Hyeon, Ko Hae Young, Chung Jee-In, Lee Misu, Park Yongmin Mason, Nam Min-Ho, Kim Jisu, Kim Seon Yoo, Park Youngjoo, Moon Ju Hyung, Kang Seok-Gu, Chang Jong Hee, Lee C Justin, Kim Se Hoon, Yun Mijin

Abstract excerpt

PURPOSE: 11 C-acetate ( 11 C-ACE) uptake on PET/CT was recently discovered to represent reactive astrocytes in the tumor microenvironment. This study aimed at evaluating the role of 11 C-ACE PET/CT as an imaging biomarker of reactive astrogliosis in characterizing different types of gliomas. METHODS: In this prospective study, a total of 182 patients underwent 11 C-ACE PET/CT before surgery. The ratio of SUV max...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetates
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Gliosis

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Positron Emission Tomography Computed Tomography

Share to Tumor Microenvironment

Source

Identifiers

PMID: 35868002
DOI: 10.1097/RLU.0000000000004341

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification.PMID 35868002Read ↗

11 C-Acetate PET/CT for Reactive Astrogliosis Outperforms 11 C-Methionine PET/CT in Glioma Classification and Survival Prediction.Semantic proximity Read ↗

The role of amino-acid PET in the light of the new WHO classification 2016 for brain tumors.Semantic proximity Read ↗

Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification.Semantic proximity Read ↗

Diagnostic Performance of [11C]Methionine Positron Emission Tomography in Newly Diagnosed and Untreated Glioma Based on the Revised World Health Organization 2016 Classification.Semantic proximity Read ↗

Diagnostic performance of multiparametric nonenhanced magnetic resonance imaging (MRI) in grading glioma and correlating IDH mutation status.Semantic proximity Read ↗

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas.Semantic proximity Read ↗

CEST MRI Provides Amides/amines Surrogate Biomarkers for Treatment-naïve Glioma Sub-typingSemantic proximity Read ↗

The diagnostic value of contrast enhancement on MRI in diffuse and anaplastic gliomas.Semantic proximity Read ↗

Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomasSemantic proximity Read ↗

Multi-tracer and multiparametric PET imaging to detect the IDH mutation in glioma: a preclinical translational in vitro, in vivo, and ex vivo study.Semantic proximity Read ↗

The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers.Semantic proximity Read ↗

Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.